Should I buy or sell MultiPlan stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MultiPlan in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MPLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MPLN, but not buy additional shares or sell existing shares. View MPLN analyst ratings or view top-rated stocks .

What is MultiPlan's stock price target for 2024?

2 brokers have issued 1-year target prices for MultiPlan's stock. Their MPLN share price targets range from $1.25 to $2.00. On average, they expect the company's share price to reach $1.63 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price. View analysts price targets for MPLN or view top-rated stocks among Wall Street analysts .

How have MPLN shares performed in 2023?

MultiPlan's stock was trading at $1.15 on January 1st, 2023. Since then, MPLN stock has increased by 13.0% and is now trading at $1.30. View the best growth stocks for 2023 here .

Are investors shorting MultiPlan?

MultiPlan saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 15,620,000 shares, a drop of 10.7% from the October 15th total of 17,490,000 shares. Based on an average trading volume of 1,010,000 shares, the days-to-cover ratio is presently 15.5 days. Currently, 5.3% of the company's stock are short sold. View MultiPlan's Short Interest .

When is MultiPlan's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our MPLN earnings forecast .

How were MultiPlan's earnings last quarter?

MultiPlan Co. (NYSE:MPLN) issued its earnings results on Tuesday, November, 7th. The company reported ($0.06) EPS for the quarter. The firm had revenue of $242.80 million for the quarter. MultiPlan had a negative net margin of 74.12% and a negative trailing twelve-month return on equity of 13.20%.

What ETF holds MultiPlan's stock ?

IQ Chaikin U.S. Small Cap ETF holds 385,810 shares of MPLN stock, representing 0.34% of its portfolio.

Who are MultiPlan's major shareholders?

MultiPlan's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Beach Point Capital Management LP (1.28%), Charles Schwab Investment Management Inc. (1.24%), Northern Trust Corp (0.54%), Bank of New York Mellon Corp (0.29%), Atalaya Capital Management LP (0.23%) and Invesco Ltd. (0.21%). Insiders that own company stock include Anthony Colaluca Jr , Corporate Investors Viii H&F, James M Head , Julie D Klapstein , Mark Tabak and Michael Kim. View institutional ownership trends .

How do I buy shares of MultiPlan?

Shares of MPLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

MultiPlan Stock Price, News & Analysis (NYSE:MPLN)

$1.29

-0.06 (-4.44%)

(As of 12/5/2023 ET)

Compare

Today's Range: $1.29
▼
$1.37
50-Day Range: $1.25
▼
$1.73
52-Week Range: $0.61
▼
$2.29

Volume: 825,809 shs
Average Volume: 1.50 million shs
Market Capitalization: $837.84 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.63

MultiPlan MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 25.0% Upside
$1.63 Price Target
Short Interest: Bearish
5.17% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.10 out of 5 stars

Medical Sector

927th out of 948 stocks

Business Services, Not Elsewhere Classified Industry

82nd out of 82 stocks

2.0

Analyst's Opinion

Consensus Rating
MultiPlan has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $1.63, MultiPlan has a forecasted upside of 25.0% from its current price of $1.30.
Amount of Analyst Coverage
MultiPlan has received no research coverage in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
5.17% of the float of MultiPlan has been sold short.
Short Interest Ratio / Days to Cover
MultiPlan has a short interest ratio ("days to cover") of 15, which indicates bearish sentiment.
Change versus previous month
Short interest in MultiPlan has recently decreased by 4.67%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
MultiPlan does not currently pay a dividend.
Dividend Growth
MultiPlan does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MPLN.

0.0

News and Social Media Coverage

MarketBeat Follows
Only 1 people have added MultiPlan to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MultiPlan insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 7.50% of the stock of MultiPlan is held by insiders.
Percentage Held by Institutions
78.47% of the stock of MultiPlan is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of MultiPlan is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of MultiPlan is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
MultiPlan has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About MultiPlan Stock (NYSE:MPLN)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It also provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. The company serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

MPLN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MPLN Stock News Headlines

November 8, 2023 | finance.yahoo.com

MultiPlan Corporation (NYSE:MPLN) Q3 2023 Earnings Call Transcript

November 8, 2023 | msn.com

MultiPlan extends $100M stock buyback program

December 6, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

November 7, 2023 | seekingalpha.com

MultiPlan Corporation 2023 Q3 - Results - Earnings Call Presentation

November 7, 2023 | msn.com

Multiplan GAAP EPS of -$0.04, revenue of $242.8M

November 7, 2023 | businesswire.com

MultiPlan Reports Third Quarter 2023 Results

November 7, 2023 | finance.yahoo.com

MultiPlan Corp (MPLN) Reports Q3 2023 Revenues of $242.8 Million, Net Loss of $24.1 Million

November 6, 2023 | msn.com

Multiplan Q3 Earnings Preview

December 6, 2023 | Financial Alphas (Ad)

Lithium Discovery So BIG You Can't Miss it, Even From Space

November 2, 2023 | investing.com

Multiplan Corp (MPLN_t)

October 27, 2023 | seekingalpha.com

MultiPlan Sees Uptick In Utilization But Revenue Growth Is A Challenge

October 26, 2023 | finance.yahoo.com

MultiPlan Corporation WT (MPLN-WT)

October 5, 2023 | stockhouse.com

MultiPlan Corporation Announces Third Quarter 2023 Earnings Conference Call

September 28, 2023 | investing.com

MPLN_t Historical Data

September 10, 2023 | fool.com

MultiPlan (NYSE: MPLN)

September 7, 2023 | finance.yahoo.com

MultiPlan Named to Prestigious 2023 Fortune Best Workplaces in Health Care List

August 24, 2023 | finance.yahoo.com

MultiPlan Earns 2023 Great Place to Work Certification™

August 10, 2023 | reuters.com

Hospital sues data analytics company MultiPlan in US court antitrust case

August 3, 2023 | seekingalpha.com

MultiPlan Corporation 2023 Q2 - Results - Earnings Call Presentation

August 2, 2023 | finance.yahoo.com

MultiPlan Reports Second Quarter 2023 Results

July 29, 2023 | nasdaq.com

MultiPlan Corporation Class A Common Stock (MPLN)

July 13, 2023 | seekingalpha.com

MultiPlan Sees Stabilizing Markets But Contracting Revenue In 2023

July 6, 2023 | finance.yahoo.com

MultiPlan Corporation Announces Second Quarter 2023 Earnings Conference Call

June 27, 2023 | finance.yahoo.com

MultiPlan Appoints John Prince to its Board of Directors

June 23, 2023 | tmcnet.com

MultiPlan Corporation to Hold Meeting of Stockholders on

June 20, 2023 | finance.yahoo.com

MultiPlan and ECHO Health Partner to Drive Health Plan Administrative Costs Down

June 14, 2023 | finance.yahoo.com

MultiPlan Named a Best Workplace in New York

See More Headlines

Receive MPLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MultiPlan and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/07/2023
Today: 12/05/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/27/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Business services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:MPLN
CUSIP: N/A
CIK: 1793229
Web: www.multiplan.us
Phone: 212-780-2000
Fax: N/A
Employees: 2,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $1.63
High Stock Price Target: $2.00
Low Stock Price Target: $1.25
Potential Upside/Downside: +25.0%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.12)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-572,910,000.00
Net Margins: -74.12%
Pretax Margin: -75.46%
Return on Equity: -13.20%
Return on Assets: -3.25%

Debt

Debt-to-Equity Ratio: 2.61
Current Ratio: 1.23
Quick Ratio: 1.23

Sales & Book Value

Annual Sales: $1.08 billion
Price / Sales: 0.78
Cash Flow: $0.56 per share
Price / Cash Flow: 2.32
Book Value: $2.80 per share
Price / Book: 0.46

Miscellaneous

Outstanding Shares: 649,490,000
Free Float: 600,775,000
Market Cap: $844.34 million
Optionable: Optionable
Beta: 0.58

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Dale A. White (Age 67)
President, CEO & Director
Comp: $3.73M
Mr. James M. Head (Age 57)
CFO & Executive VP
Comp: $500.96k
Mr. Michael C. Kim (Age 57)
Senior VP & Chief Information Officer
Comp: $727.44k
Mr. Jeffrey A. Doctoroff (Age 54)
Executive VP, General Counsel & Corporate Secretary
Comp: $736.45k
Mr. Gerald J. Kozel (Age 51)
Senior VP & Chief Accounting Officer
Mr. Lucas Gabriel Montgomery C.F.A.
Senior Vice President of Finance & Investor Relations
Ms. Melissa Humphrey
Senior Vice President of Marketing & Communications
Mr. Alwyn Van Heerdan
Vice President of Strategy & Corporate Development
Ms. Carol Nutter (Age 46)
Senior VP & Chief People Officer
Mr. Derek Reis-Larson
Senior Vice President of Claims Pricing Services

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

MPLN Stock Analysis - Frequently Asked Questions

Should I buy or sell MultiPlan stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MultiPlan in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MPLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MPLN, but not buy additional shares or sell existing shares.
View MPLN analyst ratings or view top-rated stocks.
What is MultiPlan's stock price target for 2024?: 2 brokers have issued 1-year target prices for MultiPlan's stock. Their MPLN share price targets range from $1.25 to $2.00. On average, they expect the company's share price to reach $1.63 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for MPLN or view top-rated stocks among Wall Street analysts.
How have MPLN shares performed in 2023?: MultiPlan's stock was trading at $1.15 on January 1st, 2023. Since then, MPLN stock has increased by 13.0% and is now trading at $1.30.
View the best growth stocks for 2023 here.
Are investors shorting MultiPlan?: MultiPlan saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 15,620,000 shares, a drop of 10.7% from the October 15th total of 17,490,000 shares. Based on an average trading volume of 1,010,000 shares, the days-to-cover ratio is presently 15.5 days. Currently, 5.3% of the company's stock are short sold.
View MultiPlan's Short Interest.
When is MultiPlan's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our MPLN earnings forecast.

How were MultiPlan's earnings last quarter?: MultiPlan Co. (NYSE:MPLN) issued its earnings results on Tuesday, November, 7th. The company reported ($0.06) EPS for the quarter. The firm had revenue of $242.80 million for the quarter. MultiPlan had a negative net margin of 74.12% and a negative trailing twelve-month return on equity of 13.20%.
What ETF holds MultiPlan's stock ?: IQ Chaikin U.S. Small Cap ETF holds 385,810 shares of MPLN stock, representing 0.34% of its portfolio.
Who are MultiPlan's major shareholders?: MultiPlan's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Beach Point Capital Management LP (1.28%), Charles Schwab Investment Management Inc. (1.24%), Northern Trust Corp (0.54%), Bank of New York Mellon Corp (0.29%), Atalaya Capital Management LP (0.23%) and Invesco Ltd. (0.21%). Insiders that own company stock include Anthony Colaluca Jr, Corporate Investors Viii H&F, James M Head, Julie D Klapstein, Mark Tabak and Michael Kim.
View institutional ownership trends.
How do I buy shares of MultiPlan?: Shares of MPLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:MPLN) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial